Efficacy News and Research

RSS
Comparing SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infections

Comparing SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infections

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Phage therapeutics can be used to fight multidrug-resistant pathogens

Phage therapeutics can be used to fight multidrug-resistant pathogens

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Study reveals why service dogs may improve mental health for some veterans with PTSD

Study reveals why service dogs may improve mental health for some veterans with PTSD

New technology converts discarded bullfrog skin into wound healing products

New technology converts discarded bullfrog skin into wound healing products

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Using CRISPR to Lift the Lid on Probiotics

Using CRISPR to Lift the Lid on Probiotics

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

How SARS-CoV-2 Omicron spike mutations contribute to increased infectivity

How SARS-CoV-2 Omicron spike mutations contribute to increased infectivity

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Why Omicron is more infectious than other SARS-CoV-2 variants

Why Omicron is more infectious than other SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.